缺氧对脑星状细胞GAPDH和β—Actin基因表达的影响

目的：样本ＲＮＡ加样量的差异是影响Ｎｏｒｔｈｅｒｎ杂交ＲＮＡ分析和反转录ＰＣＲ（ＲＴ－ＰＣＲ）半定量分析的重要因素。因５－磷酸甘油醛脱氢酶（ＧＡＰＤＨ）和β肌动蛋白（β－ａｃｔｉｎ）ｍＲＮＡ水平一般相对恒定,常用于基因表达研究时样本加样量的校正。但有报道表明某些因素对ＧＡＰＤＨ和β－ａｃｔｉｎ的ｍＲＮＡ水平有一定影响。脑星状细胞（ＡＣ）是近年来神经科学的研究热点之一,有关其基因的研究得到广泛的重视     

美东地区罗德河流域地下水中铝形态分布的化学平衡模式计算

美东地区的罗德河流域遭受着严重的酸沉降侵蚀．在酸性条件下,铝从土壤中大量溶解并迁移到水环境中．地表水中升高的铝浓度对鱼类产生毒害,监测地表水和土壤水中的铝形态及浓度变化已成为问题的关键．本文报导了用化学平衡模式计算法分析美东地区罗德河流域地下水中的铝形态分布,获得了有价值的结论     

A massive phytoplankton bloom induced by an ecosystem-scale iron fertilization experiment in the equatorial Pacific Ocean

The seeding of an expanse of surface waters in the equatorial Pacific Ocean with low concentrations of dissolved iron triggered a massive phytoplankton bloom which consumed large quantities of carbon dioxide and nitrate that these microscopic plants cannot fully utilize under natural conditions. These and other observations provide unequivocal support for the hypothesis that phytoplankton growth in this oceanic region is limited by iron bioavailability.     

Research fraud: false data confessed

Joseph Cort, a researcher at Mount Sinai Medical School in New York City from 1976 to 1980, has admitted fabricating data on the synthesis of hormone analogues. Cort's research at Mount Sinai was supported principally by a contract from Vega Biochemicals, though he received a small amount of support under a National Institutes of Health grant to his department.     

Genetic engineering: regulation issue is resurrected by EPA

The Environmental Protection Agency is asserting regulatory control over the commercial production of genetically-engineered microorganisms, such as oil-eating bacteria, intended for release into the environment. EPA's legally-complex claim that such organisms are "new chemical substances," and thus subject to the Toxic Substances Control Act (TSCA), raises a challenge to the adequacy of regulation by the National Institute of Health's Recombinant DNA Advisory Committee (RAC) over the commercial and ecological implications of environmental release. Industry, which has been voluntarily adhering to the RAC guidelines, is reluctant to challenge application of the relatively lenient TSCA requirements but eager to see the legal uncertainties resolved.     

Further snag with Stanford patent: filing error claimed in Cohen-Boyer

An attorney for Stanford and the University of California has conceded that there is a serious error in the second Cohen-Boyer genetic engineering patent, but he argues that the patent is still valid. In an August decision to reject the patent, the U.S. Patent Office cited the error as one of several potential flaws. The same potential flaws are found in the original Cohen-Boyer patent, as well. Also in question is whether Robert Helling of the University of Michigan should be included as a co-inventor. Further appeals could delay a final decision until the summer of 1984 or beyond.